Sujata Narayanan

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Thomas Powles, Begoña P. Valderrama, Shilpa Gupta et al. · New England Journal of Medicine · 2024 · 914 citations · Full text

Medicine, Oncology, Pharmacology +14

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik et al. · Journal of Clinical Oncology · 2019 · 590 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome

Dietlind L. Wahner‐Roedler, Eric J. Olson, Sujata Narayanan et al. · Gender Medicine · 2007 · 102 citations

Medicine, Internal Medicine, Gender +12

Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

Daniel P. Petrylak, Yohann Loriot, David R. Shaffer et al. · Clinical Cancer Research · 2021 · 79 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma

Sujata Narayanan, Neeraj Agarwal, Kristina Callis-Duffin et al. · The American Journal of the Medical Sciences · 2010 · 34 citations

Medicine, Oncology, Pharmacology +12